| Issuer | % of Class | Filed |
|---|---|---|
|
Ventyx Biosciences, Inc.
13D/A
Amendment 15
VTYX · 92332V107
|
0% |
3/5/2026
Event 3/4/2026
|
|
Ventyx Biosciences, Inc.
13D/A
Amendment 14
VTYX · 92332V107
|
5.8% |
1/9/2026
Event 1/7/2026
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.